Pharmacokinetic Analysis of Mannitol in Relation to the Decrease of ICP
Mannitol has been used for the reduction of raised intracranial pressure (ICP) for years, however, the most effective dose and the method of administration have remained controversial [2, 3]. One of the reasons is that the pharmacokinetics of mannitol has not been clearly understood in relation to the changes of mannitol concentration and serum osmolality and the decrease of ICP after the mannitol administration .
KeywordsCreatinine Rubber Mannitol Furosemide Pentobarbital
Cloyd JC, Synder BD, Cleeremans B, Bundie SR (1986) Mannitol pharmacokinetics and serum osmolality in dogs and humans. J Pharmacol Exp Ther 23:301–306Google Scholar
Marshall LF, Smith RW, Rausher LA, Shapiro HM (1978) Mannitol dose requirements in brain injured patients. J Neurosurg 48:169–172PubMedCrossRefGoogle Scholar
Roberts PA, Pollay M, Engles C, Pendleton B, Reynolds E, Stevens FL (1987) Effect on intercranial pressure of furosemide combined with various dose and administration rates of mannitol. J Neurosurg 66:440–446PubMedCrossRefGoogle Scholar
Yamaoka K (1984) Method of pharmacokinetic analysis by personal computer. Nanzando, TokyoGoogle Scholar
© Springer-Verlag Berlin Heidelberg 1993